Deep Tech Startups

Cambrium designs novel molecules and materials by combining AI with bioscience disciplines such as molecular biology, protein engineering, and material science. It develops engineered proteins and materials for industrial and commercial applications.

9 investors

CarbonBridge develops a proprietary direct gas bioprocessing platform for bioreactor operations that eliminates solubility barriers without traditional equipment like spargers or agitators. The platform serves biotech and industrial biology companies seeking higher productivity and faster response times in bioprocessing.

9 investors

Cascade Bio develops enzyme immobilization technology ("Body Armor"), a silica-based coating applied to glass-bead supports that stabilizes enzymes so they last longer and tolerate harsher conditions than other cell-free solutions. Its biocatalysts target chemical manufacturing, including food and pharmaceutical applications.

9 investors

The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure. The content is presented under Marvell branding, focused on connectivity, custom silicon, and optical DSP solutions for hyperscalers and data center customers.

9 investors

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

9 investors

CTGT develops a governance layer for AI systems that enables direct intervention at the neural network representation level to ensure reliable, policy-aligned AI behavior for enterprises. The company targets organizations that need to deploy AI responsibly with built-in accountability and control mechanisms.

9 investors

Cyrus operates a protein engineering platform that combines AI and Rosetta computational design methods with a biochemistry lab performing large-scale deep mutagenesis scanning, protein stabilization, immunogenicity reduction, and affinity/specificity tuning. It designs and re-engineers biologic therapeutics, working on internal and partnered drug programs including COVID assets and gene therapy candidates.

9 investors

Deepnight develops AI-powered night vision cameras that use edge AI processing to enable high-performance imaging in extremely low-light conditions, targeting defense, consumer electronics, drones, and autonomous vehicles. The company embeds machine learning models into digital image sensors to achieve night vision capabilities that match or exceed conventional analog systems.

9 investors

Edison Scientific builds AI agents for scientific research, enabling researchers and industries to accelerate discovery across biology, chemistry, physics, and related domains. The company combines advances in large language models and scientific reasoning to automate experimental design, literature analysis, and scientific workflows.

9 investors

Elemind makes a wearable neurotech sleep headband that measures EEG brain signals and delivers phase-locked acoustic stimulation to help users fall asleep faster and return to sleep after waking. The device pairs with a companion app for headband control and sleep tracking, and is sold to consumers with sleep difficulties.

9 investors

Ethos Space develops technology to build and operate spaceports and infrastructure on the Moon using in-situ lunar resources, including construction material (Durandal), onsite propellant production (Prometheus), and materials for space-based data centers. The company also publishes research reports on lunar and planetary resources such as silicon, water, critical minerals, and helium-3.

9 investors

FlexNode provides modular AI infrastructure solutions designed for rapid deployment at the edge. The company delivers turnkey facilities, IT systems, and operational support for AI workloads, optimized for both hyperscaler quality and edge inference deployment.

9 investors

Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.

9 investors

Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.

9 investors

FoundryLab produces metal casting parts for defense, aerospace, and automotive industries using 3D-printed ceramic molds and automated processes, delivering production-grade parts from CAD to finished product in 72 hours without tooling delays.

9 investors

General Galactic is a space infrastructure company focused on building orbital and extraterrestrial infrastructure, drawing inspiration from science fiction concepts like propellant generation for off-Earth settlement. The company frames its mission around enabling human expansion beyond Earth in the "Second Space Age."

9 investors

General Matter develops nuclear energy technology focused on domestic U.S. energy production. The company aims to reduce foreign energy reliance and support economic growth through nuclear power expansion.

9 investors

Gravitics builds space infrastructure including Orbital Carriers for on-demand payload deployment, commercial space station modules, and cargo/logistics systems based on a shared 4-meter diameter form factor. Its products target military, civil, and commercial space missions, with applications in space mobility, emergency response, and missile defense.

9 investors

Greenlyte produces e-methanol, a low-carbon synthetic fuel for deep-sea shipping, by converting CO₂ and hydrogen using renewable electricity. The company targets maritime operators facing regulatory pressure to decarbonize and reduce fuel costs under emerging IMO and EU emission standards.

9 investors

Hoxton Farms grows cultivated fat, a biomanufactured ingredient for food companies to use in plant-based and alternative meat products. The company operates a production facility in London and partners with global food manufacturers to supply this ingredient.

9 investors

Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.

9 investors

Illumix builds infrastructure for spatial AI, combining computer vision, multimodal AI, and edge deployment technologies for both consumer and enterprise applications.

9 investors

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient. The company focuses on personalized protein therapeutics for patients.

9 investors

Improbable is a venture builder and technology company that creates and scales ventures in AI, Web3, and the metaverse, drawing on over a decade of experience in large-scale multiplayer technology and virtual worlds. The company builds new ventures from the ground up and spins out internal teams into independent companies, combining capital, technical expertise, and operational support.

9 investors